Pharmaceuticals news FT.com

Drug ad ban could leave US pharma with a bad case of withdrawal

For TV network operators, the prognosis looks glum

Jun 25, 2025 - 13:50
 0
Drug ad ban could leave US pharma with a bad case of withdrawal
For TV network operators, the prognosis looks glum
Read More

Tags:

Previous Article

Biogen’s Spinraza follow-up helps children with SMA who didn’t benefit from Zolg...

Next Article

NATO orders additional A330 MRTT aircraft, onboards Denmark, Sweden

Related Posts

A look inside the US regulatory loophole that might keep weight-loss jabs affordable

A look inside the US regulatory loophole that might kee...

May 22, 2025  0

23andMe sale grafts a happy ending on to a glum tale

23andMe sale grafts a happy ending on to a glum tale

May 20, 2025  0

The race to discover life-saving drugs by sequencing new genomes

The race to discover life-saving drugs by sequencing ne...

May 31, 2025  0